In this interview, Dr. Freya Leech, a researcher at NanoFCM, discusses the current challenges and future prospects in ...

Academic, industry, and FDA collaboration is key to personalized treatment manufacturing, says Aldevron’s Max Sellman at BPI this week.

Newly launched ophthalmology company Ollin Biosciences has emerged onto the scene with $100 million in backing and a mission ...

Creative Biolabs aims to accelerate gene therapy research with state-of-the-art CRISPR screening platforms, allowing researchers to explore the function, regulation, and interaction of genes.

The speed of technological development in 2025 is almost thrilling. This article, "Top 10 Breaking Tech Innovations Changing O ...

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...

Natural systems such as CRISPR-associated transposons (CASTs) offer a targetable, one-step way to edit genomes. However, ...

Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat ...

Late-breaking data at the ESC Congress showcased the success of STX-1200, a novel CasXE-based therapy for durably lowering Lp(a). STX-1200 achieved unprecedented potency and specificity, with >90% ...

CRISPR has the power to correct genetic mutations, but current delivery methods are either unsafe or inefficient, keeping the technology from reaching its full medical potential. With the power to ...